Elevated intra-ocular pressure, chronic open-angle glaucoma

Indication for Timolol

Population group: Suitable for both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Timoptol is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.

For this indication, competent medicine agencies globally authorize below treatments:

2 drops in 2 divided doses daily

Route of admnistration


Defined daily dose

2 - 2 {drops}

Dosage regimen

From 1 To 1 {drops} 2 time(s) per day every day

Detailed description

Recommended therapy is one drop 0.25% solution in the affected eye twice a day.

If clinical response is not adequate, dosage may be changed to one drop 0.5% solution in each affected eye twice a day. If needed, Timoptol may be used with other agent(s) for lowering intra-ocular pressure. The use of two topical beta-adrenergic blocking agents is not recommended.

Intra-ocular pressure should be reassessed approximately four weeks after starting treatment because response to Timoptol may take a few weeks to stabilise.

Provided that the intra-ocular pressure is maintained at satisfactory levels, many patients can then be placed on once-a-day therapy.

Active ingredient

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

Read more about Timolol

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner